|
⚲
|
| Keyboard |
| Western Standard LLC
✚
|
|
|---|---|
| CRD # | 147864 |
| SEC # | 801-108055 |
| CIK # | 0001517666 |
| AUM | 574.9 M (2026-03-30) |
| Employees | 8 (75% Investors, 0% Brokers) |
| Phone | 310-929-4300 |
| Address | 5757 Wilshire Blvd Los Angeles, CA 90036 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Green Dot Corp | 39.8 | ||
| Compass Diversified Holdings | 24.7 | ||
| Teleflex Inc | 22.1 | ||
| Innospec Inc | 16.6 | ||
| Ambac Financial Group Inc | 10.5 | ||
| Aviat Networks Inc | 9.4 | ||
| ANGI Homeservices Inc | 8.3 | ||
| Apartment Investment & Management Co | 6.6 | ||
| YETI Holdings Inc | 5.9 | ||
| Five Below Inc | 5.3 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Western Standard Partners LP | [2015-06-25] | 174.5 M | 275.3 M |
| Filed 2025-05-22 (D/A) · Exemption 506(b), 3(c)(1), 3(c) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Western Standard Partners QP LP | [2015-06-25] | 43.9 M | 90.9 M |
| Filed 2025-05-22 (D/A) · Exemption 506(b), 3(c)(7), 3(c) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 574.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 574.9 |
| By Discretionary | ||
| Discretionary | 3 | 574.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 574.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 208.7 | |
| United States Persons | 366.2 | |
| Total | 3 | 574.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Eric Andersen | Executive Officer | 42 | 10 | |
| Western Standard LLC | Executive Officer | 2 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001517666] | |
| 3 | [0001517666] | |
| 4 | [0001517666] | |
| SC 13D | [0001517666] | |
| SC 13G | [0001517666] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 25490021H31HVN11CC78 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Merrimack Pharmaceuticals Inc | |
| Andersen Eric | |
| Western Standard Partners LP | |
| Western Standard LLC | |
| Western Standard Partners QP LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-12-28 | Buy | 857 | $13.35 | 11,441 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-12-26 | Buy | 48,693 | $13.15 | 640,313 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-12-07 | Buy | 24,666 | $12.85 | 316,958 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-12-07 | Buy | 76,384 | $12.85 | 981,534 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-17 | Buy | 235 | $12.50 | 2,938 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-17 | Buy | 65 | $12.50 | 812 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-14 | Buy | 39,283 | $12.50 | 491,038 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-14 | Buy | 10,887 | $12.50 | 136,088 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-13 | Buy | 12,191 | $12.39 | 151,046 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-13 | Buy | 3,379 | $12.39 | 41,866 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-10 | Buy | 29,803 | $12.32 | 367,173 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-10 | Buy | 8,259 | $12.32 | 101,751 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-09 | Buy | 7,810 | $12.19 | 95,204 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-09 | Buy | 2,165 | $12.19 | 26,391 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-08 | Buy | 4,783 | $12.13 | 58,018 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-08 | Buy | 9,040 | $12.13 | 109,655 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-08-08 | Buy | 68,431 | $12.00 | 821,172 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-08-08 | Buy | 18,626 | $12.00 | 223,512 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-08-07 | Buy | 49,857 | $12.00 | 598,284 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-08-07 | Buy | 84,636 | $12.00 | 1,015,632 |
| showing 20 of 54 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Boxer Capital Management LLC
✚
|
CA | 578.2 M |
|
Cello Capital Management LP
✚
|
NY | 577.2 M |
|
Tabor Asset Management LP
✚
|
NY | 577.2 M |
|
Birnam Oak Advisors LP
✚
|
NY | 577.0 M |
|
Muddy Waters Capital LLC
✚
|
TX | 576.3 M |
|
Untitled Investments LP
✚
|
NY | 574.0 M |
|
Prevatt Capital Ltd
✚
|
571.5 M | |
|
TYRO Capital Management LLC
✚
|
FL | 570.9 M |
|
Lionstone Capital Management LLC
✚
|
NY | 569.7 M |
|
INCA Investments LLC
✚
|
FL | 569.6 M |